FIELD: pharmaceutical compositions.
SUBSTANCE: present invention relates to the use of a pharmaceutical composition for buccal/gingival administration of paracetamol, consisting of a water-alcohol solution containing dissolved paracetamol, where the mass of paracetamol is from 95 mg to 190 mg, the volume of the specified aqueous-alcoholic solution is from 1.0 ml to 2 0 ml, the alcohol content (in degrees) in said water-alcohol solution is from 48.5 to 52.5%, and the concentration of paracetamol in said water-alcohol solution is from 85 mg/ml to 110 mg/ml, to increase the rate at which paracetamol passes through the blood-brain barrier.
EFFECT: creation of pharmaceutical composition for buccal/gingival administration of paracetamol.
6 cl, 7 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAL FORM FOR TRANS-MUCOUSAL PERORAL INTRODUCTION OF ANALGESIC AND/OR ANTISPASMODIC MOLECULES | 2010 |
|
RU2552345C2 |
| GALENIC FORM FOR TRANSMUCOSAL INTRODUCTION OF PARACETAMOL | 2007 |
|
RU2456984C2 |
| DERIVATIVES OF SULFONYLUREA OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON DERIVATIVES OF SULFONYLUREA SHOWING ANTITUMOR ACTIVITY | 1994 |
|
RU2127259C1 |
| NEW COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING, AND SYNTHESIS, NANO-STRUCTURE AND USE THEREOF | 2014 |
|
RU2660901C2 |
| MELATONIN-BASED SOLUTIONS AND POWDERS FOR THEIR PREPARATION | 2012 |
|
RU2646802C2 |
| SUBSTITUTED N-PIPERIDINO-5-(4-CHLOROPHENYL)-1-(2,4-DICHLORO-PHENYL)-4-METHYLPYRAZOLE-3-CARBOXAMIDE OR ITS SALTS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1994 |
|
RU2141479C1 |
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| INITIAL ANTICONVULSANT COMPOSITIONS AND A METHOD FOR ADMINISTERING ANTICONVULSANT AGENTS | 2000 |
|
RU2264209C2 |
| OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL | 2019 |
|
RU2818244C2 |
| GLYCOSAMINOGLYCANES APPLIED FOR TREATING SENILE FEEBLE-MINDEDNESS | 2000 |
|
RU2248800C2 |
